Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Gutmann, Hanna
DOB: 18-FEB-1969 (Age: 57)
Gender: female
ID: 1078-407870-0 (ECI)
Author
Schweiger, Manuel
Patient summary Document
European Patient Summary
Report Date: 20-AUG-2024

Problem list

Condition Onset Date / Period Status
Anemia 23-Jul-2019 active
Malignant neoplasm of breast 29-Aug-1989 active
Acute viral pharyngitis 28-Apr-2025 - 09-May-2025 inactive
Laceration of thigh 13-Mar-2023 - 05-Apr-2023 inactive
Laceration - injury 13-Mar-2023 - 05-Apr-2023 inactive
Concussion with no loss of consciousness 31-Dec-2021 - 16-Feb-2022 inactive
Concussion injury of brain 31-Dec-2021 - 16-Feb-2022 inactive
Acute bronchitis 22-May-2017 - 29-May-2017 inactive

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 20-Aug-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 05-Jul-2016
Live attenuated Human alphaherpesvirus 3 only vaccine product 05-Jul-2016

Procedure History list

Procedure Date Reason
Suture open wound 13-Mar-2023 Laceration of thigh (disorder)
Screening for substance abuse 30-May-2017 -
Medication reconciliation 30-May-2017 -
Assessment of health and social care needs 30-May-2017 -
Screening for domestic abuse 30-May-2017 -
Assessment of substance use 30-May-2017 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Diabetes self management plan 23-Jul-2019 Prediabetes (finding)
  • Patient will achieve and maintain target fasting plasma glucose as part of prediabetes management.

Vital Signs

Vital Signs 2025-04-28 2024-08-20
Body temperature 37 Cel -
Body Height - 157.6 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported - 2 {score}
Body Weight - 70 kg
Body mass index (BMI) [Ratio] - 28.2 kg/m2
Heart rate - 83 /min
Respiratory rate - 13 /min
Blood pressure panel with all children optional - 77 mm[Hg]

Relevant diagnostic tests/laboratory data

Recent Lab Observations 20-AUG-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.0 - 5.6 %
Glucose [Mass/volume] in Blood 65.1 L 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 11.6 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.7 0.5 - 1.1 mg/dL
Calcium [Mass/volume] in Blood 9.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 138.2 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.9 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 107.7 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.2 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 230.2 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 118.8 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 180.6 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 25.9 L 40 - 60 mg/dL

Device Use

Device Date (since)
Blood glucose meter (physical object) 23-Jul-2019